Literature DB >> 15215108

Beneficial influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus-induced endocarditis.

Renee-Claude Mercier1, Robert M Dietz, Jory L Mazzola, Arnold S Bayer, Michael R Yeaman.   

Abstract

Platelets contribute to antimicrobial host defense against infective endocarditis (IE) by releasing platelet microbicidal proteins (PMPs). We investigated the influence of thrombin-stimulated human platelets on the evolution of simulated IE in the presence and absence of vancomycin or nafcillin. Staphylococcus aureus strains differing in intrinsic susceptibility to PMPs or antibiotics were studied: ISP479C (thrombin-induced PMP-1 [tPMP-1] susceptible; nafcillin and vancomycin susceptible), ISP479R (tPMP-1 resistant; nafcillin and vancomycin susceptible), and GISA-NJ (tPMP-1 intermediate-susceptible; vancomycin intermediate-susceptible). Platelets were introduced and thrombin activated within the in vitro IE model 30 min prior to inoculation with S. aureus. At 0 to 24 h postinoculation, bacterial densities in chamber fluid and simulated endocardial vegetations (SEVs) were quantified and compared among groups. Activated platelets alone, or in combination with antibiotics, inhibited the proliferation of ISP479C in chamber fluid or SEVs over the initial 4-h period (P < 0.05 versus controls). Moreover, nafcillin-containing regimens exerted inhibitory effects beyond 4 h against ISP479C in both model phases. By comparison, activated platelets inhibited GISA-NJ proliferation in SEVs but not in chamber fluid. The combination of platelets plus nafcillin or vancomycin significantly inhibited proliferation of the GISA-NJ strain in SEVs compared to the effect of platelets or antibiotics alone (P < 0.05). In contrast, platelets did not significantly alter the antistaphylococcal efficacies of nafcillin or vancomycin against ISP479R. These data support our hypothesis that a beneficial antimicrobial effect may result from the interaction among platelets, PMPs, and anti-infective agents against antibiotic-susceptible or -resistant staphylococci that exhibit a tPMP-1-susceptible or -intermediate-susceptible phenotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15215108      PMCID: PMC434186          DOI: 10.1128/AAC.48.7.2551-2557.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  33 in total

1.  Thrombin-induced platelet microbicidal protein susceptibility phenotype influences the outcome of oxacillin prophylaxis and therapy of experimental Staphylococcus aureus endocarditis.

Authors:  V K Dhawan; A S Bayer; M R Yeaman
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  Inhibition of intracellular macromolecular synthesis in Staphylococcus aureus by thrombin-induced platelet microbicidal proteins.

Authors:  Yan-Qiong Xiong; Arnold S Bayer; Michael R Yeaman
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

3.  Synergistic interactions between mammalian antimicrobial defense peptides.

Authors:  H Yan; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Experimental bacterial endocarditis. I. Colonization of a sterile vegetation.

Authors:  D T Durack; P B Beeson
Journal:  Br J Exp Pathol       Date:  1972-02

5.  Antimicrobial peptides from human platelets.

Authors:  Yi-Quan Tang; Michael R Yeaman; Michael E Selsted
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation.

Authors:  Tayebeh Youssefian; Arnaud Drouin; Jean-Marc Massé; Josette Guichard; Elisabeth M Cramer
Journal:  Blood       Date:  2002-06-01       Impact factor: 22.113

7.  In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiological, histopathologic, and echocardiographic analyses.

Authors:  Leon Iri Kupferwasser; Michael R Yeaman; Shelley M Shapiro; Cynthia C Nast; Arnold S Bayer
Journal:  Circulation       Date:  2002-02-12       Impact factor: 29.690

8.  An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.

Authors:  M Vaara; P Viljanen; T Vaara; P H Mäkelä
Journal:  J Immunol       Date:  1984-05       Impact factor: 5.422

9.  Effect of thrombocytopenia on the early course of streptococcal endocarditis.

Authors:  P M Sullam; U Frank; M R Yeaman; M G Täuber; A S Bayer; H F Chambers
Journal:  J Infect Dis       Date:  1993-10       Impact factor: 5.226

10.  Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus.

Authors:  M R Yeaman; D C Norman; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

View more
  12 in total

1.  Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates.

Authors:  Kati Seidl; Arnold S Bayer; Vance G Fowler; James A McKinnell; Wessam Abdel Hady; George Sakoulas; Michael R Yeaman; Yan Q Xiong
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

2.  Implications of the innate immune response to adenovirus and adenoviral vectors.

Authors:  Seth M Gregory; Shoab A Nazir; Jordan P Metcalf
Journal:  Future Virol       Date:  2011-03       Impact factor: 1.831

3.  Platelet-rich plasma lysate displays antibiofilm properties and restores antimicrobial activity against synovial fluid biofilms in vitro.

Authors:  Jessica M Gilbertie; Thomas P Schaer; Alicia G Schubert; Megan E Jacob; Stefano Menegatti; R Ashton Lavoie; Lauren V Schnabel
Journal:  J Orthop Res       Date:  2020-01-14       Impact factor: 3.494

Review 4.  Platelets: at the nexus of antimicrobial defence.

Authors:  Michael R Yeaman
Journal:  Nat Rev Microbiol       Date:  2014-06       Impact factor: 60.633

5.  Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function.

Authors:  George Sakoulas; George M Eliopoulos; Vance G Fowler; Robert C Moellering; Richard P Novick; Natalie Lucindo; Michael R Yeaman; Arnold S Bayer
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

6.  Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.

Authors:  Manjunath P Pai; Marie L Samples; Renee-Claude Mercier; Michael N Spilde
Journal:  Antimicrob Agents Chemother       Date:  2008-04-21       Impact factor: 5.191

Review 7.  Staphylococcus aureus infections in children.

Authors:  James E Cassat; Isaac Thomsen
Journal:  Curr Opin Infect Dis       Date:  2021-10-01       Impact factor: 4.968

8.  Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds.

Authors:  Tao Li; Yu Ma; Min Wang; Tao Wang; Jing Wei; Rui Ren; Min He; Guixue Wang; Johnson Boey; David G Armstrong; Wuquan Deng; Bing Chen
Journal:  Infect Drug Resist       Date:  2019-01-29       Impact factor: 4.003

9.  Proteomic and Membrane Lipid Correlates of Reduced Host Defense Peptide.

Authors:  Christian Kohler; Richard A Proctor; Arnold S Bayer; Michael R Yeaman; Michael Lalk; Susanne Engelmann; Nagendra N Mishra
Journal:  Antibiotics (Basel)       Date:  2019-09-28

Review 10.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.